Sarah Ketterer (Trades, Portfolio)’s Causeway International Value (Trades, Portfolio) added two holdings to its portfolio during the fourth quarter. They are AstraZeneca PLC (LSE:AZN, Financial) and Gildan Activewear Inc. (TSX:GIL, Financial).
Founded by Ketterer in 2001, Causeway Capital Management’s fund seeks long-term growth of capital and income. The fund generally invests in international companies with market caps greater than $750 million.
The fund purchased 305,959 shares of AstraZeneca for an average price of 45.11 pounds ($54.89) per share, giving it 0.3% portfolio space.
AstraZeneca is a London-based biopharmaceutical company specializing in treatments for cardiovascular and metabolic diseases, oncology, respiratory ailments, inflammation and autoimmunity, neuroscience and infections and vaccines. The company has a market cap of 58.7 billion pounds; its shares were trading around 47.56 pounds on Thursday with a price-earnings (P/E) ratio of 25.9, a forward P/E ratio of 16.03, a price-book (P/B) ratio of 5.1 and a price-sales (P/S) ratio of 3.5.
The Peter Lynch chart below shows the stock is trading above its fair value.
GuruFocus ranked AstraZeneca’s financial strength 5 of 10 and its profitability and growth 5 of 10. The trailing dividend yield and forward dividend yield are 4.6%.
The Vanguard Health Care Fund (Trades, Portfolio) is the company’s largest guru shareholder with 2.5% of outstanding shares, which represents 4% of its total assets managed.
The fund bought 551,900 shares of Gildan Activewear for an average price of 35.55 Canadian dollars ($26.33) per share, expanding the portfolio 0.2%.
Gildan produces basic family apparel including T-shirts, fleece jackets, underwear and socks. The Canadian company has a market cap of $7.9 billion; its shares were trading around CA$34.31 on Thursday with a P/E ratio of 17.8, a forward P/E ratio of 15.5, a P/B ratio of 2.8 and a P/S ratio of 2.4.
The Peter Lynch chart below shows the stock is trading above its fair value.
GuruFocus ranked the company’s financial strength 7 of 10 and its profitability and growth 9 of 10. The trailing dividend yield is 1.24% and the forward dividend yield is 1.43%. Over the past five years, the company has grown its dividend at a rate of 30.5% per year.
The Signature Select Canadian Fund (Trades, Portfolio) is Gildan’s largest guru shareholder with 0.2% of outstanding shares, which represents 0.9% of its total assets managed.
The fund’s current portfolio is composed of 57 stocks. Health care stocks have a weight of 8.7% on the portfolio, whereas consumer cyclical stocks have a weight of 9.9%.
Disclosure: I do not own any stocks mentioned in the article.
Start a free 7-day trial of Premium Membership to GuruFocus.
